Alnylam Pharma (ALNY) Tops Q2 EPS by 15c
Tweet
Share
E-mail
Get Alerts ALNY Hot Sheet
Price: $242.61 --0%
Financial Fact:
Comprehensive loss: -109.41M
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
Comprehensive loss: -109.41M
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
Alnylam Pharma (NASDAQ: ALNY) reported Q2 EPS of ($1.07), $0.15 better than the analyst estimate of ($1.22). Revenue for the quarter came in at $15.93 million versus the consensus estimate of $22.31 million.
For earnings history and earnings-related data on Alnylam Pharma (ALNY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Starts Alnylam Pharmaceuticals (ALNY) at Outperform
- ATRenew Inc (RERE) Tops Q2 EPS by 8c ; Offers Guidance
- Analog Devices (ADI) Tops Q3 EPS by 11c, Beats on Revenue; Offers Q4 Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
